Patient Preferences on Same-day Bilateral Intravitreal Dexamethasone Injections

RecruitingOBSERVATIONAL

Enrollment

200

Participants

Timeline

Start Date

January 13, 2025

Primary Completion Date

December 31, 2025

Study Completion Date

January 31, 2026

Conditions

Informed ConsentPreference, Patient

Interventions

DRUG

Ozurdex (dexamethasone)

Intravitreal dexamethasone implant (Ozurdex) given according to the recommendations by the manufacturer.

Trial Locations (1)

RECRUITING

Department of Ophthalmology, Rigshospitalet, Glostrup Municipality

All Listed Sponsors

lead

Rigshospitalet, Denmark

OTHER